Robert J. Schotzinger

Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis

Tatiana Y. Hargrove, Laura Friggeri, Z. Wawrzak et al. · Journal of Biological Chemistry · 2017 · 408 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Effects of Pyridoxamine in Combined Phase 2 Studies of Patients with Type 1 and Type 2 Diabetes and Overt Nephropathy

Mark E. Williams, W. Kline Bolton, Raja G. Khalifah et al. · American Journal of Nephrology · 2007 · 245 citations

Medicine, Pharmacology, Pharmacotherapy +17

Cholinergic phenotype developed by noradrenergic sympathetic neurons after innervation of a novel cholinergic target in vivo

Robert J. Schotzinger, Story C. Landis · Nature · 1988 · 208 citations

Life Sciences, Neurobiology, Neuroscience +16

Design and optimization of highly-selective fungal CYP51 inhibitors

William J. Hoekstra, Edward P. Garvey, William R. Moore et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 181 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme

Andrew G. S. Warrilow, Claire M. Hull, Josie E. Parker et al. · Antimicrobial Agents and Chemotherapy · 2014 · 166 citations · Full text

Medicine, Microbiology, Pharmacology +17